CVE-2026-1037: IBM Common Licensing

Medium severity, CVSS 6.1. EPSS: 0.2% chance of exploitation in the next 30 days.

IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

Affected products

• IBM Common Licensing

Published 2026-09-18. Last modified 2026-09-18.